Escandos stamina and longs.Ed, you have the stamina of a freaking stallion for this.
Personally I am inclined to sit back and let the people hoping for the same news we already had to keep selling me their shares for a loss, I’ll take all I can get.
Serious advice for new people posting though, if you are looking at this for a pure short term cannabis play you will most likely be disappointed.
Glen Rehman (CEO) said himself in the Midas video that cannabis sales are projected to be less than half of their sales to begin with.
Neuenergy is their main product line, along with Bluscience, which is a patent that was valued at $6 mil, and they have confirmed that they still have plans for Bluscience.
That was all in place well before the July news of a partnership to make thc tablets, and will be well in place long after sales are flowing in that one product. It may fail.
Conversely, there are a significant percentage of shares in this company that are held by people that already knew this before cannabis was even a topic, and you can be sure we aren’t selling. The potential that this company has with crysolation, blue science, neuenergy, and a team of executives and Ambassadors that are a true who’s who list Ian simply worth more than anybody can convince us to sell for in the near future. Good luck to all, and seriously do your own due diligence on this. First and foremost in psterolbine which is already an active ingredient in their main product. Cheers.